This study helps to understand the data on the fenestrated Anaconda endograft is restricted to case series with a little example size. This investigation was performed to evaluate the specialized and clinical result of this gadget in an enormous worldwide case series.  All overall communities having treated in excess of 15 complex stomach aortic aneurysms (AAA) or type IV thoracoabdominal aortic aneurysm patients with the fenestrated Anaconda endograft were drawn closer. Fundamental result boundaries were procedural specialized achievement, postoperative and follow-up clinical result for endoleaks, target vessel patency, reintervention rate, and patient endurance. 

300 35 continuous cases treated between June 2010 and May 2018 of every 11 destinations were incorporated. Patients were treated for a short neck infrarenal (n = 98), juxtarenal (n = 191), suprarenal AAA (n = 27), or type IV thoracoabdominal aortic aneurysm (n = 19). Mean age was 73.6 ± 4.6 years (292 male). Endografts contained an aggregate of 920 fenestrations, with a mean of 2.7 ± 0.8 fenestrations per case. Specialized achievement was 88.4% (essential, 82.7%; helped essential 5.7%). In 6.9% of cases, a procedural sort IA endoleak was noticed, suddenly vanishing in 82.6% during early development. The advancement of a sort IA endoleak was related with more prominent neck angulation.

Reference link-